Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cecolin 9 Lot-to-Lot Consistency Trial in Chinese Females
NCT07668271Phase 4Recruiting
- Sponsor
- Xiamen Innovax Biotech Co., Ltd.
- Start
- May 2026
- Primary completion
- Feb 2027
- Countries
- 1
01
Overview
A Phase 4 trial of Cecolin 9 in human papillomavirus infection, sponsored by Xiamen Innovax Biotech Co., Ltd.. Started May 2026; status: recruiting.
02
Drugs
Cecolin 9
03
Conditions
human papillomavirus infection
Beyond the preview
Go deeper on NCT07668271.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07668271.